Celltrion eyes record high sales in 2025, fueled by high-margin biosimilars

Celltrion Inc., South Korea’s leading biosimilar drug developer, is poised to reap nearly 5 trillion won ($3.6 billion) in revenue this year a...

S.Korea’s most prominent business leader returns with all charges cleared

After nearly a decade spent fighting allegations of corporate wrongdoing, Samsung Electronics Co. Chairman Lee Jae-yong has been acquitted on all ch...

Celltrion secures $730 mn to buy biosimilar unit shares, pursue M&A

Celltrion Holdings Co. has secured 1 trillion won ($732 million) in fresh funding and plans to spend half of it this year to buy shares in its biosi...

Miri Capital closes in on STIC Investments chairman’s stake

Miri Capital Management LLC has steadily raised its stake in STIC Investments Inc., narrowing the ownership gap with the firm’s founder and Ch...

Celltrion shares rise after bonus issue announcement   

Celltrion Inc., South Korea’s largest biosimilar developer, will issue bonus shares to bolster its stock performance, which has been in the do...

Bill Clinton in Seoul to meet with MBK's ByungJu Kim, business leaders

Michael ByungJu Kim, co-founder, partner and chairman of Seoul-based private equity firm MBK Partners Ltd., is set to meet with former US President ...

S.Korea’s Naver to launch Silicon Valley venture arm in aggressive AI push

Naver Corp., South Korea’s top internet portal operator, plans to set up a dedicated venture capital arm in Silicon Valley in a move seen as a...

Hanjin KAL roars on hints of renewed control dispute with Hoban

Shares of Hanjin KAL Corp., the holding firm of South Korean flag carrier Korean Air Lines Co., extended their rally Wednesday after surging by the ...

Celltrion unveils cancer medicine to expand new drug pipelines

South Korea’s leading biosimilar drug developer Celltrion Inc. on Sunday unveiled an anticancer medicine to expand new pipelines and accelerat...

Mirae Asset bets on China as Korean investors’ US focus draws concern

South Korea’s leading asset manager Mirae Asset Financial Group is increasingly unveiling China-focused investment products as Chairman P...

Celltrion expands footprint in Latin America with flagship oncology drugs

South Korea’s biopharmaceutical giant Celltrion Inc. has solidified its presence in South America after winning supply contracts for its flags...

SK chairman in Taiwan to deepen ties with TSMC

Chey Tae-won, chairman of SK Group, the parent of SK Hynix Inc., is visiting Taiwan amid the threat of escalating US tariff threats, suggesting the ...

Celltrion wins Australian approval for eye, bone disease biosimilars

Celltrion Inc. said Wednesday it has received regulatory approval from Australia’s Therapeutic Goods Administration (TGA) for three biosimilar...

Korea Zinc faces multiple legal, regulatory challenges in fight against MBK

Korea Zinc Inc. Chairman Choi Yun-birm appears to have kept his grip on the world’s largest zinc smelter after successfully fending off an MBK...

MBK sees better exit landscape in 2025, bets on governance reform

MBK Partners sees a recovery in the exit environment in 2025 and seeks to capitalize on the opportunities emerging from corporate governance reform ...

Hanwha gears up for 3rd-generation leadership with chairman’s stake gift

South Korea’s chemical-to-defense conglomerate Hanwha Group Chairman Kim Seung-youn will hand over half of his holdings in the conglomerate&rs...

Celltrion to sell autoimmune drug Stelara biosimilar at Costco in US

South Korea’s leading biosimilar drug developer Celltrion Inc. said on Monday it is set to sell Steqeyma, a biosimilar to autoimmune disease t...

Samsung Chairman Lee meets with Xiaomi CEO Lei Jun for partnership

BEIJING – Samsung Electronics Co. Chairman Lee Jae-yong has met with Xiaomi Inc. Chief Executive Lei Jun in the Chinese capital, raising specu...

MBK chairman to leverage own funds to pay Homeplus suppliers

Michael ByungJu Kim, the co-founder, partner and chairman of Northeast Asia-focused private equity firm (PEF) MBK Partners Ltd., is expected to leve...

Celltrion to cancel $140 mn in treasury shares, stock up

South Korea’s leading biosimilar drug developer Celltrion Inc. announced on Friday a plan to cancel $140 million worth of treasury shares to i...

Samsung, Celltrion lead biosimilar market in Europe, US

Samsung Bioepis Co. and Celltrion Inc. are outpacing long-established global drug manufacturers such as Amgen Inc. and Sandoz in the antibody biosim...

Affinity, GIC sell out of Kyobo Life; Chairman Shin seeks holding firm, M&A

Affinity Equity Partners and Singapore’s sovereign wealth fund GIC have sold their entire stake in Kyobo Life Insurance Co., exiting from thei...

MBK commits to restoring Homeplus operations: MBK Vice Chairman Kim

MBK Partners, facing increasing scrutiny over its highly leveraged acquisition of Homeplus Co., has pledged to go all-out to restore the struggling ...

LG Group chair visits India ahead of LG Electronics Indian IPO

LG Group Chairman Koo Kwang-mo visited LG Electronics Inc.'s factory and research center in India in late February as it plans to list its Indian ar...

Celltrion wins EU approval for autoimmune disease treatment Avtozma

Celltrion Inc.’s Avtozma, a biosimilar to Roche’s autoimmune disease treatment Actemra, has won approval from the European Commission, f...

Mirae Asset prepares bitcoin covered call ETF launch: chairman

Mirae Asset Financial Group is preparing to launch a bitcoin covered call exchange traded fund (ETF) for global investors to foray into the cryptocu...

LG, SNU team up to develop AI modeling for protein structure predictions

LG AI Research Institute, the artificial intelligence think-tank of LG Group, South Korea’s fourth-biggest conglomerate, on Thursday signed a ...

Celltrion’s Vegzelma: Most-prescribed cancer treatment in Europe

South Korea’s leading biosimilar drug developer Celltrion Inc.'s Vegzelma, a cancer drug referencing global biopharma Roche’s Avastin, h...

Samsung set to rebuild with leader Lee cleared of all charges

Samsung Electronics Co. Chairman Lee Jae-yong was found not guilty of accounting fraud, stock manipulation and other criminal charges by a Seoul app...

HD KSOE wins $2.6 bn order for 12 container ships

South Korea’s largest shipbuilder HD Korea Shipbuilding & Offshore Engineering Co. (HD KSOE) said on Thursday it got 3.716 trillion won ...